Bristol Myers Squibb BMY
NYSE BMY
$60.92 +2.08 (+3.54%)
As of: Oct 20, 2026 · 10:16 AM EDT

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Total Non-Current Liabilities of $60.97 billion in Q2 2026, down 15.6% from $72.25 billion a year earlier and down 0.9% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb reported Total Non-Current Liabilities of $66.49 billion, down 7.3% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $71.75 billion in FY2024 (+21.1%), $59.25 billion in FY2023 (+0.2%), $59.11 billion in FY2022 (-10.4%) and $65.97 billion in FY2021 (-9.4%).
  • The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q4 2023.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for three consecutive quarters, with growth averaging 1.0% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 35.9% in Q1 2024, against a decline of 15.6% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $61.52 billion (Q1 2026), $66.49 billion (Q4 2025) and $72.83 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,158.69 Bn 1,127.28 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 622.73 Bn 541.26 Bn 17.26 Bn 105.50 Bn
3 AbbVie 509.26 Bn 482.37 Bn 12.70 Bn 106.45 Bn
4 Merck 365.63 Bn 320.01 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 295.70 Bn 259.69 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 260.09 Bn 233.78 Bn 12.86 Bn 33.91 Bn
7 Amgen 234.27 Bn 189.67 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.77 Bn 117.42 Bn 10.94 Bn 97.04 Bn
10 Bristol Myers Squibb 124.21 Bn 75.49 Bn 9.25 Bn 60.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.97 Bn
Mar 31, 2026 61.52 Bn
Dec 31, 2025 66.49 Bn
Sep 30, 2025 72.83 Bn
Jun 30, 2025 72.25 Bn
Mar 31, 2025 70.50 Bn
Dec 31, 2024 71.75 Bn
Sep 30, 2024 71.74 Bn
Jun 30, 2024 72.58 Bn
Mar 31, 2024 75.75 Bn
Dec 31, 2023 59.25 Bn
Sep 30, 2023 56.00 Bn
Jun 30, 2023 55.56 Bn
Mar 31, 2023 55.73 Bn
Dec 31, 2022 59.11 Bn
Sep 30, 2022 58.78 Bn
Jun 30, 2022 61.06 Bn
Mar 31, 2022 64.08 Bn
Dec 31, 2021 65.97 Bn
Sep 30, 2021 66.09 Bn
API Access

Bristol Myers Squibb Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BMY&period=max&api_key=YOUR_API_KEY